Holen Sie sich die Stockscreener-App
3.57
1.42%
0.05
Handel nachbörslich:
3.52
-0.05
-1.40%
Schlusskurs vom Vortag:
$3.52
Offen:
$3.72
24-Stunden-Volumen:
41,589
Relative Volume:
0.66
Marktkapitalisierung:
$30.19M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.81M
KGV:
-1.237
EPS:
-2.8859
Netto-Cashflow:
$-17.01M
1W Leistung:
-9.39%
1M Leistung:
-27.14%
6M Leistung:
-65.17%
1J Leistung:
-60.60%
1-Tages-Spanne:
$3.45
$3.72
1-Wochen-Bereich:
$3.45
$4.00
52-Wochen-Spanne:
$1.98
$13.48
Cel-Sci Corp. Stock (CVM) Company Profile
Firmenname
Cel-Sci Corp.
Sektor
Branche
Telefon
703-506-9460
Adresse
8229 Boone Boulevard, Suite 802, Vienna, VA
Compare CVM vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVM
Cel-Sci Corp.
|
3.57 | 29.77M | 0 | -23.81M | -17.01M | -2.8859 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cel-Sci Corp. Stock (CVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-01-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-03-02 | Eingeleitet | Dawson James | Buy |
Cel-Sci Corp. Aktie (CVM) Neueste Nachrichten
Volume Recap: Is Regencell Bioscience Holdings Limited stock a smart retirement pickJuly 2025 Macro Moves & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Cel-Sci (CVM) Reports Narrower Q1 Net Loss - GuruFocus
CEL-SCI Reports Fiscal First Quarter 2026 Results - Investing News Network
Cancer therapy lifted 5-year survival to 73% in trial; next test in 2026 - Stock Titan
Cel-Sci: Fiscal Q1 Earnings Snapshot - kens5.com
Cel-Sci: Overview of First Fiscal Quarter Financial Results - Bitget
CEL SCI CORP SEC 10-Q Report - TradingView
Big Money Moves: Does CEL SCI Corporation stock have upside surprise potential - baoquankhu1.vn
Investment Review: Is CEL SCI Corporation trading at a discountJuly 2025 Snapshot & Comprehensive Market Scan Reports - baoquankhu1.vn
IPO Launch: Is CEL SCI Corporation trading at a discountWeekly Trading Summary & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Cel-Sci (NYSEAMERICAN:CVM) Stock Price Down 6.9% – Should You Sell? - Defense World
Why did CVM shares rally over 7% today? - MSN
Why DID CVM Shares Rally Over 7% Today? - Asianet Newsable
Kersten Geert buys Cel Sci (CVM) shares worth $200000 By Investing.com - Investing.com Australia
Insider Buying: Geert Kersten Acquires Additional Shares of CEL-SCI Corp (CVM) - GuruFocus
Kersten Geert buys Cel Sci (CVM) shares worth $200000 - Investing.com
Profit Recap: Does CEL SCI Corporation stock have upside surprise potentialWeekly Investment Report & Stepwise Trade Signal Implementation - baoquankhu1.vn
Cel Sci (CVM) Options Delisting Set for January 20th - GuruFocus
Surprises Report: Why CEL SCI Corporation stock could outperform in 2025M&A Rumor & AI Enhanced Trading Alerts - Bộ Nội Vụ
Cel-Sci (NYSEAMERICAN:CVM) Stock Price Down 6.5% – What’s Next? - Defense World
Cel-Sci Corporation (CVM) Investor Outlook: Exploring A Potential 625% Upside - DirectorsTalk Interviews
Is CEL SCI Corporation stock dividend yield sustainable2025 Geopolitical Influence & Long-Term Safe Investment Ideas - Улправда
Is CEL SCI Corporation stock positioned well for digital economyJuly 2025 Selloffs & Expert Curated Trade Setup Alerts - Улправда
Is CEL SCI Corporation stock a contrarian buyPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Cel-sci-sci Corp : Dutton Associates Announces Investment Opinion - marketscreener.com
CEL-SCI (CVM) Chief Scientific Officer reports purchase of 456 shares - Stock Titan
CEL-SCI (CVM) CFO Patricia Prichep reports insider stock purchase - Stock Titan
CEL-SCI Corp (CVM) CEO and Director reports purchase of 998 shares - Stock Titan
Cel-Sci Corporation (CVM) Stock Analysis: Exploring a Potential 707% Upside with Innovative Cancer Therapies - DirectorsTalk Interviews
Cel-Sci (CVM) Reduces R&D Costs and Narrows Net Loss in FY 2025 - GuruFocus
Cancer drug Multikine nears final U.S. trial, seeks Saudi breakthrough status - Stock Titan
CEL SCI CORP SEC 10-K Report - TradingView — Track All Markets
CEL-SCI Reports Fiscal 2025 Results - Investing News Network
CEL-SCI (NYSE American: CVM) details Multikine survival data and cash outlook - Stock Titan
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Why CEL SCI Corporation stock is rated strong buyWeekly Risk Report & Safe Swing Trade Setups - Улправда
CEL SCI Corp CEO Acquires 8,389 Shares - TradingView — Track All Markets
CEL-SCI Corp (CVM) CEO Geert Kersten reports insider purchase of 8,389 shares - Stock Titan
Can Cel Sci Corporation stock deliver double digit returns2025 Earnings Impact & Safe Capital Allocation Plans - Newser
Will CEL SCI Corporation (LSR) stock gain from lower interest ratesJuly 2025 Analyst Calls & Free Daily Entry Point Trade Alerts - Newser
Will CEL SCI Corporation (LSR) stock attract long term capital inflowsJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - Newser
Is CEL SCI Corporation (LSR) stock resilient in recession scenarios2025 Top Decliners & Community Verified Trade Alerts - Newser
Why CEL SCI Corporation (LSR) stock is upgraded to buy2025 Short Interest & Daily Volume Surge Trade Alerts - Newser
How reliable is Cel Sci Corporation stock dividend growthJuly 2025 Movers & Smart Swing Trading Techniques - Newser
Why Cel Sci Corporation stock is upgraded to buyJuly 2025 Intraday Action & AI Enhanced Execution Alerts - Newser
CEL-SCI (CVM) Stock Analysis Report | Financials & Insights - Benzinga
How CEL SCI Corporation (LSR) stock trades under stagflationJuly 2025 Opening Moves & Technical Pattern Alert System - Newser
Why Cel Sci Corporation stock stays undervaluedEarnings Trend Report & Daily Technical Forecast Reports - Newser
Cel-Sci revises shareholder rights agreement following board approval By Investing.com - Investing.com South Africa
Finanzdaten der Cel-Sci Corp.-Aktie (CVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):